Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) informed ...

Vanda Pharmaceuticals Inc. (Vanda) today announced that the U.S. Food and Drug Administration (FDA) informed Vanda that the New Drug Application (NDA) for Bysantitm (milsaperidone) has been filed, and ...

WASHINGTON, May 2, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (VNDA) today announced it will release results for the first quarter 2025 on Wednesday, May 7, 2025, after the market closes.

Vanda Pharmaceuticals (VNDA), another stock in the same industry, has yet to report results for the quarter ended March 2025. This biopharmaceutical company is expected to post quarterly loss of $ ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

According to the CDC, arthritis affects more than 50 million Americans, and nearly 26 million of those with arthritis are unable to do everyday activities. The Joint Corp. , the nation's largest ...

NEW YORK - AJ Jones II has built his career on taking risks, starting with leaving his hometown of Houston for Iowa State ...

Tarsus Pharmaceuticals, Inc. (TARS) came out with a quarterly loss of $0.64 per share versus the Zacks Consensus Estimate of a loss of $0.69. This compares to loss of $1.01 per share a year ago. These ...